Invest in Your Future.
Agensmed is the innovative implementer of the latest findings from the BioMed Center Innovation and its partners. What thrives at Agensmed stems from real demand, identified through direct communication with users. Solutions grow from this demand, rigorously developed and scientifically validated. Only when technical and regulatory risks are under control are these solutions implemented into economically sound applications. Once the time is right, we gladly place them in capable hands to unlock their full potential for the future, allowing us to reap the rewards of our development together – while new seeds are already being sown.
Agensmed offers fascinating projects with tremendous potential, consistently opening new dimensions in medicine and delivering key solutions. For patients, this represents the future of medicine – for you, it is a lucrative opportunity to participate in the growth of these ideas.
Browse through our list of investment projects and take the chance to shape the medicine of tomorrow. Contact us today for further details and investor materials.
RePore 3D
Genuine bone mineral, directly from the printer in any shape, purely inorganic and fully optimized for regeneration – we were among the first to achieve this solution. Already distributed in veterinary medicine, clinical approval for human use is now imminent. The second round of capital investment is open. Come on board.
Subperiosteal Implant
Born out of the renowned INKplant project and developed in direct collaboration with the Kepler University Hospital in Linz, this solution uses Lithoz ceramic 3D-printing technology. The result is a groundbreaking solution for supplying dental prosthetics where implants cannot be placed. Preparations for the clinical phase are underway, and fundraising for clinical approval is now open.
Palatal Cleft Implant for Newborns
A cleft palate is a relatively common congenital defect that makes feeding very complicated and can lead to middle ear infections. Within the EU INKplant project, and in cooperation with leading specialists from MedUni Vienna, a completely novel, patented solution has been developed, which also restores muscle function. The implant is currently in the preclinical phase, and we are seeking early investors for this project in the first funding round.
